IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice

Cell Biology International

Volumn 39, Issue 4, 2015, Pages 388-399

  Lei, Ling ^a   Zhong, Xiao Ning ^a   He, Zhi Yi ^a   Zhao, Cheng ^a   Sun, Xue Jiao ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

CD4+ T cells; Interleukin 17; Interleukin 21; Systemic sclerosis; Th17 cells

Indexed keywords

HYDROXYPROLINE; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 21; BLEOMYCIN; IL17A PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DERMATITIS; FEMALE; IN VITRO STUDY; LUNG LESION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; T CELL CULTURE; TH17 CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CELL DIFFERENTIATION; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; SKIN; UPREGULATION;

MUS;

ANIMALS; BLEOMYCIN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; HYDROXYPROLINE; INTERLEUKIN-17; INTERLEUKINS; LUNG; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SCLERODERMA, SYSTEMIC; SKIN; TH17 CELLS; UP-REGULATION;

EID: 84925301412     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10410     Document Type: Article

References (39)

1. Varga J, Abraham D ( 2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117(3): 557-6.
2. Gabrielli A, Avvedimento EV, Krieg T ( 2009) Scleroderma. N Engl J Med 360(19): 1989-2003.
3. O'Reilly S, Hügle T, van Laar JM ( 2012) T cells in systemic sclerosis: a reappraisal. Rheumatology 51(9): 1540-9.
4. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT ( 2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11): 1123-32.
5. Pernis AB ( 2009) Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 65(6): 644-52.
6. Stockinger B, Veldhoen M, Martin B ( 2007) Th17 T cells: linking innate and adaptive immunity. Semin Immunol 19(6): 353-61.
7. Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Takabayashi K, Iwamoto I ( 2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43(11): 2455-63.
8. Fenoglio D1, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, Rizzi M, Kalli F, Conteduca G, Ghio M, De Palma R, Indiveri F, Filaci G ( 2011) Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol 139(3): 249-57.
9. Rodríguez-Reyna TS, Furuzawa-Carballeda J, Cabiedes J, Fajardo-Hermosillo LD, Martínez-Reyes C, Díaz-Zamudio M, Llorente L ( 2012) Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int 32(9): 2653-60.
10. Lei L, Zhong XN, Zhao C, Mi CD, Li JQ, Zeng JJ ( 2012) Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis. Beijing Da Xue Xue Bao 44(2): 259-64.
11. Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, Strom TB, Oukka M, Kuchroo VK ( 2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H) 17 cells. Nature 448(7152): 484-7.
12. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS, Jetten AM, Dong C ( 2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448(7152): 480-3.
13. Monteleone G, Pallone F, Macdonald TT ( 2009) Interleukin-21 as a new therapeutic target for immune-mediated diseases. Trends Pharmacol Sci 30(8): 441-7.
14. Dolff S, Abdulahad WH, Westra J, Doornbos-van der Meer B, Limburg PC, Kallenberg CG, Bijl M ( 2011) Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res Ther 13(5): 157.
15. Tzartos JS, Craner MJ, Friese MA, Jakobsen KB, Newcombe J, Esiri MM, Fugger L ( 2011) IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain. Am J Pathol 178(2): 794-802.
16. Pallone F, Fina D, Caruso R, Monteleone G ( 2010) Role of IL-21 in inflammatory bowel disease. Expert Rev Clin Immunol 6(4): 537-41.
17. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR ( 2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8(9): 967-74.
18. Yamamoto T ( 2006) The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis. Arch Dermatol Res 297(8): 333-44.
19. Yoshizaki A, Iwata Y, Komura K, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S ( 2008) CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 172(6): 1650-63.
20. Ishikawa H, Takeda K, Okamoto A, Matsuo S, Isobe K ( 2009) Induction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4+ T cells. J Invest Dermatol 129(7): 1688-95.
21. Yamamoto T, Takagawa S, Katayama I, Mizushima Y, Nishioka K ( 1999) Effect of superoxide dismutase on bleomycin-induced dermal sclerosis: implications for the treatment of systemic sclerosis. J Invest Dermatol 113(5): 843-7.
22. Fineschi S, Bongiovanni M, Donati Y, Djaafar S, Naso F, Goffin L, Argiroffo CB, Pache JC, Dayer JM, Ferrari-Lacraz S, Chizzolini C ( 2008) In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis. Am J Respir Cell Mol Biol 39(4): 458-65.
23. Ashcroft T, Simpson JM, Timbrell V ( 1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41(4): 467-70.
24. Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC ( 2002) Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 168(6): 3088-9.
25. D'hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA ( 2005) Time course of cigarette, smoke-induced pulmonary, inflammation in mice. Eur Respir J 26(2): 204-13.
26. Ju S, Zhang D, Wang Y, Ni H, Kong X, Zhong R ( 2006) Correlation of the expression levels of BlyS and its receptors mRNA in patients with systemic lupus erythematosus. Clin Biochem 39(12): 1131-7.
27. Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, Nishioka K ( 1999) Animal model of sclerotic skin I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 112(4): 456-62.
28. Miossec P, Korn T, Kuchroo VK ( 2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361(9): 888-9.
29. Papp G, Horvath IF, Barath S, Gyimesi E, Sipka S, Szodoray P, Zeher M ( 2011) Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis. Scand J Rheumatol 40(3): 205-10.
30. Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Akiyama Y, Muroi E, Hara T, Ogawa F, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S ( 2010) Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 185(4): 2502-15.
31. Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C ( 2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes insystemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13(5): R166.
32. Yang X, Yang J, Xing X, Wan L, Li M ( 2014). Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction Arthritis. Res Ther 16(1): R4.
33. Okamoto Y, Hasegawa M, Matsushita T, Hamaguchi Y, Huu DL, Iwakura Y, Fujimoto M, Takehara K ( 2012) Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum 64(11): 3726-35.
34. Truchetet ME, Brembilla NC, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni PL, Chizzolini C ( 2013) Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 65(5): 1347-56.
35. Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban JF Jr, Cheever AW, Young DA, Collins M, Grusby MJ, Wynn TA ( 2006) The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 116(7): 2044-55.
36. Distler JH, Jüngel A, Kowal-Bielecka O, Michel BA, Gay RE, Sprott H, Matucci-Cerinic M, Chilla M, Reich K, Kalden JR, Müller-Ladner U, Lorenz HM, Gay S, Distler O ( 2005) Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum 52(3): 856-64.
37. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, Watowich SS, Tian Q, Jetten AM, Dong C ( 2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORalpha and RORgamma. Immunity 28(1): 29-3.
38. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C ( 2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282(13): 9358-63.
39. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR ( 2006) The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17 T helper cells. Cell 126(6): 1121-33.